Newsroom

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Perio...

LOS ANGELES--(BUSINESS WIRE)--Telesign, a Proximus Global company and a leader in digital identity and programmable communications, has partnered with B2Metric, an AI-native Customer Data Platform and predictive analytics company. Together, they are helping enterprises solve a critical customer engagement challenge: turning data into timely, trusted, and relevant action. Combining B2Metric’s predictive analytics with Telesign’s secure Messaging API for WhatsApp and email, the partnership enable...

FOLSOM, Calif.--(BUSINESS WIRE)--Magnit Global Hires Amy Bush as President of Client Services...

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee. In connection with the conference, there will be a live broadcast and replay of the Company’s presentati...

ROANOKE, Va.--(BUSINESS WIRE)--Foot Levelers, today announced its first-ever ‘Founder’s Edition’ event being held at its headquarters October 24-25, 2026 featuring Dr. Ronald Oberstein and Dr. Brian Jensen. Foot Levelers, the global standard and world’s leading provider of custom stabilizing orthotics, is hosting its famous PracticeXcelerator program with the option to include Continuing Education Units and offering a rare “behind-the-scenes tour” of the Foot Levelers manufacturing facility in...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): The Annual General Meeting and Extraordinary General Meeting will be held at Medincell’s headquarters (3 rue des Frères Lumière, 34830 Jacou, France) on Wednesday, September 30, 2026, at 6:00 p.m. CEST. The notice was published in the “BALO” (French): https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2026/0826/202608262603475.pdf The resolutions proposed for voting at the General Assembly include: Approv...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News : Medincell (Paris:MEDCL) : L’Assemblée générale ordinaire annuelle et extraordinaire se tiendra au siège de Medincell (3 rue des Frères Lumière, 34830 Jacou) le mercredi 30 septembre 2026 à 18h00, heure de Paris. La convocation a été publiée au BALO : https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2026/0826/202608262603475.pdf Les résolutions proposées au vote de l’Assemblée générale portent notamment sur : L’approbation des...

LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ) (the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced its participation at Quantum World Congress 2026, taking place Sept. 23-25, 2026, in College Park, Maryland. Infleqtion leaders will participate in multiple sessions throughout the event, including roundtable discussions focused on the advancement and application of quantum technologies. Quantum World Congress brings...

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in personalized 3D-printed orthopedic solutions, today announced the launch of MyFit by restor3d Digital Suite, a new patient engagement ecosystem designed to provide patients with greater visibility into their personalized orthopedic journey while creating a seamless connection between patients, surgeons, and long-term clinical outcomes. MyFit by restor3d extends restor3d’s commitment to personalization beyond implant design and into the patien...

NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced the launch of Ataraxis ARC (the Ataraxis Real-World Clinical Outcomes Registry), a prospective, multi-site, observational study. ARC is a first-of-its-kind prospective study of AI-based tools in oncology, linking AI tool predictions with real-world short- and long-term patient outcomes.ARC will initially enroll approximately 1,000 patients acr...